{"AllianceGenome": "2909", "HGNC": "2909", "MIM": "602768", "_id": "10683", "_version": 1, "accession": {"genomic": ["AC011500.7", "AH009222.2", "CH471126.1", "CP068259.2", "NC_000019.10", "NC_060943.1", "NG_008256.1"], "protein": ["AAF62542.1", "AAH00218.1", "BAC11535.1", "EAW56905.1", "EAW56906.1", "NP_058637.1", "NP_982353.1", "Q9NYJ7.1"], "rna": ["AA865362.1", "AK075302.1", "AK308460.1", "BC000218.2", "BQ420593.1", "DB035825.1", "NM_016941.4", "NM_203486.3"], "translation": [{"protein": "NP_058637.1", "rna": "NM_016941.4"}, {"protein": "BAC11535.1", "rna": "AK075302.1"}, {"protein": "AAH00218.1", "rna": "BC000218.2"}, {"protein": "NP_982353.1", "rna": "NM_203486.3"}]}, "alias": "SCDO1", "ensembl": {"gene": "ENSG00000090932", "protein": ["ENSP00000205143", "ENSP00000348810", "ENSP00000471688"], "transcript": ["ENST00000205143", "ENST00000356433", "ENST00000596614", "ENST00000600437", "ENST00000600579"], "translation": [{"protein": "ENSP00000348810", "rna": "ENST00000356433"}, {"protein": "ENSP00000471688", "rna": "ENST00000596614"}, {"protein": "ENSP00000205143", "rna": "ENST00000205143"}], "type_of_gene": "protein_coding"}, "entrezgene": "10683", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.5982535432, "exp_mis": 242.432815818, "exp_syn": 134.245096918, "lof_z": 1.00421395407208, "mis_z": 2.62094289731088, "mu_lof": 1.25280086121e-06, "mu_mis": 3.50581367238e-05, "mu_syn": 1.95928797806e-05, "n_lof": 9.0, "n_mis": 159.0, "n_syn": 101.0, "p_li": 1.65028093606891e-05, "p_null": 0.333736576983755, "p_rec": 0.666246920206884, "syn_z": 1.77880313453651}, "bp": 1857, "cds_end": 39998653, "cds_start": 39989614, "n_exons": 8, "nonpsych": {"exp_lof": 11.2721464168, "exp_mis": 219.294610464, "exp_syn": 121.374278813, "lof_z": 0.957153039018595, "mis_z": 2.73485313616465, "mu_lof": 1.25280086121e-06, "mu_mis": 3.50581367238e-05, "mu_syn": 1.95928797806e-05, "n_lof": 8.0, "n_mis": 139.0, "n_syn": 96.0, "p_li": 6.09530091513844e-05, "p_null": 0.321756764128875, "p_rec": 0.678182282861974, "syn_z": 1.45008746217607}, "nontcga": {"exp_lof": 11.5776744987, "exp_mis": 223.02548786, "exp_syn": 123.492775869, "lof_z": 1.03722129817227, "mis_z": 2.43616698509485, "mu_lof": 1.25280086121e-06, "mu_mis": 3.50581367238e-05, "mu_syn": 1.95928797806e-05, "n_lof": 8.0, "n_mis": 150.0, "n_syn": 94.0, "p_li": 6.65090395345599e-05, "p_null": 0.27410289421707, "p_rec": 0.725830596743396, "syn_z": 1.68041861124274}, "transcript": "ENST00000205143.4"}, "exons": [{"cdsend": 39508013, "cdsstart": 39498974, "chr": "19", "position": [[39498946, 39499043], [39499191, 39499473], [39500614, 39500672], [39502814, 39503057], [39504070, 39504288], [39505228, 39505451], [39507038, 39507618], [39507829, 39508469]], "strand": 1, "transcript": "NM_016941", "txend": 39508469, "txstart": 39498946}, {"cdsend": 39508257, "cdsstart": 39498974, "chr": "19", "position": [[39498946, 39499043], [39499191, 39499473], [39500614, 39500672], [39502814, 39503057], [39504070, 39504288], [39505228, 39505451], [39507038, 39507618], [39507829, 39507914], [39508251, 39508469]], "strand": 1, "transcript": "NM_203486", "txend": 39508469, "txstart": 39498946}], "exons_hg19": [{"cdsend": 39998653, "cdsstart": 39989614, "chr": "19", "position": [[39989586, 39989683], [39989831, 39990113], [39991254, 39991312], [39993454, 39993697], [39994710, 39994928], [39995868, 39996091], [39997678, 39998258], [39998469, 39999109]], "strand": 1, "transcript": "NM_016941", "txend": 39999109, "txstart": 39989586}, {"cdsend": 39998897, "cdsstart": 39989614, "chr": "19", "position": [[39989586, 39989683], [39989831, 39990113], [39991254, 39991312], [39993454, 39993697], [39994710, 39994928], [39995868, 39996091], [39997678, 39998258], [39998469, 39998554], [39998891, 39999109]], "strand": 1, "transcript": "NM_203486", "txend": 39999109, "txstart": 39989586}], "generif": [{"pubmed": 11923214, "text": "We suggest that the three human DLL3 mutations associated with spondylocostal dysplasia are also functionally equivalent to the Dll3(neo) null allele in mice."}, {"pubmed": 12746394, "text": "mutations in DLL3 cause a consistent pattern of abnormal vertebral segmentation in spondylocostal dysostosis"}, {"pubmed": 15717203, "text": "no novel or previously described mutations are present in our cohort, indicating that DLL3 mutations may not be a major cause of congenital scoliosis."}, {"pubmed": 18676613, "text": "The intracellular region of Notch ligands Dll1 and Dll3 regulates their trafficking and signaling activity"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 23337976, "text": "DLL3 was silenced by methylation in human human hepatocellular carcinoma and it negatively regulates the growth of human hepatocellular carcinoma cells."}, {"pubmed": 27472720, "text": "Both global haplotype and individual haplotype analyses showed that the haplotypes of SNP1/SNP2/SNP3/SNP4/SNP5 did not correlate with the disease (P >0.05). Together, these data suggest that genetic variants of the DLL3 gene are not associated with CS in the Chinese Han population."}, {"pubmed": 28007595, "text": "The Dll3 was rarely detectable in the para-carcinoma tissues, but positive in 82.1% of non-small cell cancer tissues."}, {"pubmed": 28705113, "text": "our results indicated epidermal growth factor-like domain multiple 7 protein participates in growth hormone-secreting pituitary adenoma proliferation and invasion regulation via Notch2/DLL3 signaling pathway. These findings raised the possibility that epidermal growth factor-like domain multiple 7 protein might serve as a useful biomarker to assess growth hormone-secreting pituitary adenoma invasion and prognosis"}, {"pubmed": 29290251, "text": "these results reveal that DLL3 is expressed in tumor specimens from most patients with small cell lung cancer"}, {"pubmed": 29512761, "text": "Results indicated that DLL3 expression was silenced in hepatocellular carcinoma (HCC) cells by DNA methylation and was more readily affected by histone acetylation than histone methylation (H3K9me2 or H3K27me3)."}, {"pubmed": 29555949, "text": "DLL3 expression is silenced during hepatocarcinogenesis in association with HBV infection via an epigenetic mechanism"}, {"pubmed": 30327311, "text": "Overexpression of DLL3 mRNA and protein is common in small-cell bladder cancer (SCBC) and correlates with shorter overall survival . A DLL3-targeted antibody-drug conjugate demonstrated in vivo efficacy superior to chemotherapy in a PDX model of SCBC."}, {"pubmed": 30397180, "text": "DLL3 is selectively and homogeneously expressed in IDH-mutant gliomas and can be targeted with Rova-T in patient-derived IDH-mutant glioma tumorspheres."}, {"pubmed": 30572444, "text": "The DLL3 expression could be a potential and novel tumor marker for early diagnosis and an independent predictor of poor survival for patients with endometrial cancer"}, {"pubmed": 30874360, "text": "Results showed that DLL3 downregulation attenuated small cell lung cancer (SCLC)-cell proliferation, migration and invasion in a process involving the attenuation of Snail activation. In addition, DLL3 overexpression promoted subcutaneous tumor growth in the mouse models."}, {"pubmed": 30894499, "text": "DLL3 is preferentially expressed in castration-resistant neuroendocrine prostate cancer and provide rationale for targeting DLL3 in patients with DLL3-positive metastatic prostate cancer."}, {"pubmed": 31079917, "text": "LIN28B and miR-518d-5p could regulate DLL3-mediated cell proliferation and migration."}, {"pubmed": 31215500, "text": "Delta-like ligand 3 (DLL3) is an inhibitory Notch ligand that is highly expressed in Small cell lung cancer (SCLC) and other neuroendocrine tumors but minimally expressed in normal tissues. It is therefore being explored as a potential therapeutic target in SCLC. [review]"}, {"pubmed": 31369178, "text": "Results showed that DLL3 localized in normal neuroendocrine cells. Considerable upregulation of DLL3 was found in gastrointestinal neuroendocrine carcinoma cell lines. Its silencing caused significant growth inhibition and induction of intrinsic apoptosis. This study suggests that DLL3, expressed in neuroendocrine cells of the gastrointestinal tract, has a pivotal role in gastrointestinal neuroendocrine carcinoma."}, {"pubmed": 31447005, "text": "DLL3 expression is reliably quantifiable by pathologists and is highly expressed in the majority of SCLC and a subset of carcinoid tumors, making it an attractive target for anti-DLL3 treatment."}, {"pubmed": 31678831, "text": "DLL3 is expressed at high frequency (74%) in stage IV pulmonary large cell neuroendocrine carcinoma and is a potential therapy target."}, {"pubmed": 32554516, "text": "A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer."}, {"pubmed": 32691982, "text": "DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC."}, {"pubmed": 33031101, "text": "TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection."}, {"pubmed": 33409812, "text": "Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms."}, {"pubmed": 34107132, "text": "Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview."}, {"pubmed": 34184566, "text": "Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis."}, {"pubmed": 34931456, "text": "ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China."}, {"pubmed": 35983951, "text": "DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms."}], "genomic_pos": {"chr": "19", "end": 39508481, "ensemblgene": "ENSG00000090932", "start": 39498895, "strand": 1}, "genomic_pos_hg19": {"chr": "19", "end": 39999121, "start": 39989535, "strand": 1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0001501", "pubmed": 10742114, "qualifier": "involved_in", "term": "skeletal system development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001756", "qualifier": "involved_in", "term": "somitogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007219", "qualifier": "involved_in", "term": "Notch signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007386", "qualifier": "involved_in", "term": "compartment pattern specification"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045746", "qualifier": "involved_in", "term": "negative regulation of Notch signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048339", "qualifier": "involved_in", "term": "paraxial mesoderm development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050768", "qualifier": "involved_in", "term": "negative regulation of neurogenesis"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 10742114, "qualifier": "located_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005112", "qualifier": "enables", "term": "Notch binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0005112", "pubmed": 10742114, "qualifier": "enables", "term": "Notch binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005509", "qualifier": "enables", "term": "calcium ion binding"}]}, "homologene": {"genes": [[9544, 697453], [9598, 736571], [9606, 10683], [9615, 484508], [9913, 505993], [10090, 13389], [10116, 114125]], "id": 7291}, "interpro": [{"desc": "EGF-like domain", "id": "IPR000742", "short_desc": "EGF-like_dom"}, {"desc": "EGF-like calcium-binding domain", "id": "IPR001881", "short_desc": "EGF-like_Ca-bd_dom"}, {"desc": "Growth factor receptor cysteine-rich domain superfamily", "id": "IPR009030", "short_desc": "Growth_fac_rcpt_cys_sf"}, {"desc": "Notch ligand, N-terminal domain", "id": "IPR011651", "short_desc": "Notch_ligand_N"}, {"desc": "EGF-like, conserved site", "id": "IPR013032", "short_desc": "EGF-like_CS"}], "ipi": ["IPI00021010", "IPI00409625"], "map_location": "19q13.2", "name": "delta like canonical Notch ligand 3", "other_names": ["delta-like 3", "delta-like protein 3", "delta3", "drosophila Delta homolog 3"], "pantherdb": {"HGNC": "2909", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1096877", "ortholog_type": "LDO", "panther_family": "PTHR24044", "taxid": 10090, "uniprot_kb": "O88516"}, {"RGD": "70953", "ortholog_type": "LDO", "panther_family": "PTHR24044", "taxid": 10116, "uniprot_kb": "O88671"}, {"ZFIN": "ZDB-GENE-000125-4", "ortholog_type": "O", "panther_family": "PTHR24044", "taxid": 7955, "uniprot_kb": "Q9IAT6"}, {"ZFIN": "ZDB-GENE-980526-114", "ortholog_type": "LDO", "panther_family": "PTHR24044", "taxid": 7955, "uniprot_kb": "O57409"}], "uniprot_kb": "Q9NYJ7"}, "pathway": {"kegg": [{"id": "hsa04330", "name": "Notch signaling pathway - Homo sapiens (human)"}, {"id": "hsa04658", "name": "Th1 and Th2 cell differentiation - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)"}], "netpath": {"id": "Pathway_Notch", "name": "Notch"}, "pid": {"id": "notch_pathway", "name": "Notch signaling pathway"}, "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9793380", "name": "Formation of paraxial mesoderm"}, {"id": "R-HSA-9824272", "name": "Somitogenesis"}], "wikipathways": [{"id": "WP2064", "name": "Neural Crest Differentiation"}, {"id": "WP268", "name": "Notch Signaling"}, {"id": "WP3413", "name": "NOTCH1 regulation of endothelial cell calcification"}, {"id": "WP3845", "name": "Canonical and non-canonical Notch signaling"}, {"id": "WP4239", "name": "Epithelial to mesenchymal transition in colorectal cancer"}, {"id": "WP4262", "name": "Breast cancer pathway"}, {"id": "WP4785", "name": "Somitogenesis in the context of spondylocostal dysostosis"}, {"id": "WP4787", "name": "Osteoblast differentiation"}, {"id": "WP61", "name": "Notch Signaling Pathway Netpath"}]}, "pfam": ["PF00008", "PF07657", "PF12661"], "pharmgkb": "PA27365", "pharos": {"target_id": 5897, "tdl": "Tbio"}, "prosite": "PS50026", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF261799", "relationship": "is"}, {"id": "GNF261800", "relationship": "is"}, {"id": "GNF261801", "relationship": "is"}, {"id": "GNF261802", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF038033", "relationship": "weakly similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF081683", "relationship": "is"}, {"id": "GNF081684", "relationship": "is"}, {"id": "GNF081685", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053019", "relationship": "is"}, {"id": "GNF057786", "relationship": "is"}, {"id": "GNF072917", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068905", "relationship": "is"}, {"id": "GNF068906", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF003693", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098079", "relationship": "is"}, {"id": "GNF137734", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_008256.1"], "protein": ["NP_058637.1", "NP_982353.1"], "rna": ["NM_016941.4", "NM_203486.3"], "translation": [{"protein": "NP_058637.1", "rna": "NM_016941.4"}, {"protein": "NP_982353.1", "rna": "NM_203486.3"}]}, "reporter": {"HG-U133_Plus_2": ["219537_x_at", "222898_s_at", "229755_x_at", "230568_x_at"], "HTA-2_0": "TC19000549.hg.1", "HuEx-1_0": "3833122", "HuGene-1_1": "8028719", "HuGene-2_1": "16862078"}, "summary": "This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].", "symbol": "DLL3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414071"}, "unigene": "Hs.127792", "uniprot": {"Swiss-Prot": "Q9NYJ7", "TrEMBL": "M0R177"}, "wikipedia": {"url_stub": "DLL3"}}